Search Page

1

Cite

Share

Biomarkers in chronic kidney disease, from kidney function to kidney damage.

Lopez-Giacoman S, Madero M. Lopez-Giacoman S, et al. Among authors: madero m. World J Nephrol. 2015 Feb 6;4(1):57-73. doi: 10.5527/wjn.v4.i1.57. World J Nephrol. 2015. PMID: 25664247 Free PMC article. Review.

Cite

Share

2

Cite

Share

Adiponectin and mortality in patients with chronic kidney disease.

Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, Pereira AA, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ. Menon V, et al. Among authors: madero m. J Am Soc Nephrol. 2006 Sep;17(9):2599-606. doi: 10.1681/ASN.2006040331. Epub 2006 Aug 2. J Am Soc Nephrol. 2006. PMID: 16885405 Free article.

Cite

Share

3

Cite

Share

Serum cystatin C as a marker of glomerular filtration rate.

Madero M, Sarnak MJ, Stevens LA. Madero M, et al. Curr Opin Nephrol Hypertens. 2006 Nov;15(6):610-6. doi: 10.1097/01.mnh.0000247505.71915.05. Curr Opin Nephrol Hypertens. 2006. PMID: 17053476 Review.

Cite

Share

4

Cite

Share

Long-term outcomes in nondiabetic chronic kidney disease.

Menon V, Wang X, Sarnak MJ, Hunsicker LH, Madero M, Beck GJ, Collins AJ, Kusek JW, Levey AS, Greene T. Menon V, et al. Among authors: madero m. Kidney Int. 2008 Jun;73(11):1310-5. doi: 10.1038/ki.2008.67. Epub 2008 Mar 12. Kidney Int. 2008. PMID: 18337713 Free article. Clinical Trial.

Cite

Share

5

Cite

Share

Cystatin C associates with arterial stiffness in older adults.

Madero M, Wassel CL, Peralta CA, Najjar SS, Sutton-Tyrrell K, Fried L, Canada R, Newman A, Shlipak MG, Sarnak MJ; Health ABC Study. Madero M, et al. J Am Soc Nephrol. 2009 May;20(5):1086-93. doi: 10.1681/ASN.2008030318. Epub 2009 Apr 8. J Am Soc Nephrol. 2009. PMID: 19357259 Free PMC article.

Cite

Share

6

Cite

Share

Association of cystatin C with adverse outcomes.

Madero M, Sarnak MJ. Madero M, et al. Curr Opin Nephrol Hypertens. 2009 May;18(3):258-63. doi: 10.1097/mnh.0b013e328326f3dd. Curr Opin Nephrol Hypertens. 2009. PMID: 19374014 Free PMC article. Review.

Cite

Share

7

Cite

Share

Markers of mineral metabolism are not associated with aortic pulse wave velocity in community-living elderly persons: the Health Aging and Body Composition study.

Madero M, Wassel CL, Peralta CA, Najjar SS, Sutton-Tyrrell K, Fried LF, de Boer IH, Shlipak MG, Newman AB, Hausman D, Sarnak MJ, Kritchevsky SB, Ix JH; Health ABC Study. Madero M, et al. Am J Hypertens. 2011 Jul;24(7):755-61. doi: 10.1038/ajh.2011.43. Epub 2011 Mar 24. Am J Hypertens. 2011. PMID: 21436791 Free PMC article.

Cite

Share

8

Cite

Share

Creatinine-based formulae for estimating glomerular filtration rate: is it time to change to chronic kidney disease epidemiology collaboration equation?

Madero M, Sarnak MJ. Madero M, et al. Curr Opin Nephrol Hypertens. 2011 Nov;20(6):622-30. doi: 10.1097/MNH.0b013e32834ba210. Curr Opin Nephrol Hypertens. 2011. PMID: 21941179 Review.

Cite

Share

9

Cite

Share

Serum uric acid independently predicts cardiovascular events in advanced nephropathy.

Kanbay M, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E, Unal HU, Arslan E, Verim S, Madero M, Caglar K, Oguz Y, McFann K, Johnson RJ. Kanbay M, et al. Among authors: madero m. Am J Nephrol. 2012;36(4):324-31. doi: 10.1159/000342390. Epub 2012 Sep 22. Am J Nephrol. 2012. PMID: 23007099 Free article.

Cite

Share

10

Cite

Share

Association of arterial rigidity with incident kidney disease and kidney function decline: the Health ABC study.

Madero M, Peralta C, Katz R, Canada R, Fried L, Najjar S, Shlipak M, Simonsick E, Lakatta E, Patel K, Rifkin D, Hawkins M, Newman A, Sarnak M; Health ABC Study. Madero M, et al. Clin J Am Soc Nephrol. 2013 Mar;8(3):424-33. doi: 10.2215/CJN.07900812. Epub 2012 Dec 27. Clin J Am Soc Nephrol. 2013. PMID: 23271800 Free PMC article.

Cite

Share